Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
30.77
+1.52 (5.20%)
At close: Jun 26, 2026, 4:00 PM EDT
30.00
-0.77 (-2.50%)
After-hours: Jun 26, 2026, 6:54 PM EDT
Ultragenyx Pharmaceutical Revenue by Geography
History
| Date | North America | Latin America | Europe | Japan |
|---|---|---|---|---|
| Mar 31, 2026 | 378.21M | 157.11M | 115.67M | 18.72M |
| Dec 31, 2025 | 377.00M | 170.00M | 108.00M | 18.00M |
| Sep 30, 2025 | 361.22M | 149.83M | 103.33M | 12.64M |
| Jun 30, 2025 | 354.58M | 144.47M | 97.65M | 9.79M |
| Mar 31, 2025 | 340.56M | 150.40M | 87.45M | 8.69M |
| Dec 31, 2024 | 340.46M | 130.71M | 80.12M | 5.40M |
| Sep 30, 2024 | 316.40M | 130.30M | 69.60M | 6.40M |
| Jun 30, 2024 | 307.30M | 109.50M | 60.40M | 4.10M |
| Mar 31, 2024 | 297.70M | 89.70M | 54.20M | 1.00M |
| Dec 31, 2023 | 307.10M | 77.30M | 47.60M | 2.20M |
| Sep 30, 2023 | 299.00M | 67.40M | 42.70M | 1.20M |
| Jun 30, 2023 | 298.20M | 64.30M | 38.10M | 2.40M |
| Mar 31, 2023 | 286.20M | 57.70M | 37.60M | 2.40M |
| Dec 31, 2022 | 281.00M | 44.70M | 36.40M | 1.20M |
| Sep 30, 2022 | 267.10M | 41.80M | 33.20M | 1.20M |
| Jun 30, 2022 | 267.00M | 35.20M | 32.00M | - |
| Mar 31, 2022 | 275.30M | 27.40M | 29.20M | - |
| Dec 31, 2021 | 301.10M | 23.60M | 26.60M | - |
| Sep 30, 2021 | 312.90M | 21.40M | 25.10M | - |
| Jun 30, 2021 | 318.70M | 17.70M | 22.90M | - |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.